The Effects of Expiratory Muscle Strength Training in Women With Stress Urinary Incontinence
NCT07693920
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT Number: NCT06665698
Evaluate quality of life and rate of reoperation after implantation of the I-STOP sling for stress urinary incontinence
Trial opening soon.
Get Notified18 year and older
Female
Observational
This is a prospective, multicenter, non-comparative, interventional post-marketing clinical follow-up study (PMCF) on a population of patients with SUI requiring surgical treatment with implantation of an I-STOP sling to document safety, the performance and effectiveness in the short, medium, and long term of these I-STOP® implants used in their intended purpose.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year after surgery and after each year during 10 years
Questionnaire sent every year to the patient with question about revision surgery: yes / no
Time frame: One year after surgery and after each year during 10 years
Questionnaire sent every year: Pelvic Floor Impact Questionnaire-short form 7 (PFIQ-7)
Contact information is provided by the study sponsor or research team.
DILO Medical
Industry
Prospective Study to the Evaluate the Long-term Use of Synthetic I-STOP® Device for Treatment of Stress Urinary Incontinence in Women
Acronym: VIGI-ISTOP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07693920
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT07600697
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Los Angeles, California, United States
View Trial DetailsNCT07608146
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Hefei, Anhui, China
View Trial DetailsNCT07553884
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Toronto, Onatrio, Canada
View Trial Details